WCM Investment Management
AZN icon

WCM Investment Management’s AstraZeneca AZN Stock Holding History

WCM Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249M Buy
+1,310,660
New +$247M 0.45% 44
2026
Q1 		– Sell
-1,331,310
Closed -$246M – 265
2025
Q4 		$246M Sell
1,331,310
-570
-0% -$100K 0.51% 42
2025
Q3 		$197M Buy
1,331,880
+5,339
+0.4% +$808K 0.41% 40
2025
Q2 		$185M Sell
1,326,541
-674,994
-34% -$94.6M 0.42% 38
2025
Q1 		$295M Buy
2,001,535
+136,268
+7% +$19.7M 0.76% 37
2024
Q4 		$245M Sell
1,865,267
-103,964
-5% -$14.6M 0.58% 43
2024
Q3 		$306M Sell
1,969,231
-23,912
-1% -$3.86M 0.69% 43
2024
Q2 		$312M Buy
1,993,143
+451,127
+29% +$67.9M 0.74% 41
2024
Q1 		$209M Buy
1,542,016
+24,889
+2% +$3.3M 0.5% 43
2023
Q4 		$204M Sell
1,517,127
-981,726
-39% -$128M 0.56% 39
2023
Q3 		$338M Sell
2,498,853
-51,766
-2% -$7.07M 0.99% 35
2023
Q2 		$365M Sell
2,550,619
-23,314
-0.9% -$3.43M 1.09% 33
2023
Q1 		$357M Buy
2,573,933
+238,240
+10% +$32.1M 1.14% 31
2022
Q4 		$317M Sell
2,335,693
-87,224
-4% -$10.9M 1.06% 30
2022
Q3 		$266M Buy
2,422,917
+2,420,613
+105,061% +$307M 0.96% 35
2022
Q2 		$309K Sell
2,304
-348
-13% -$45.7K ﹤0.01% 200
2022
Q1 		$352K Buy
2,652
+224
+9% +$26.9K ﹤0.01% 196
2021
Q4 		$283K Buy
2,428
+181
+8% +$21.3K ﹤0.01% 201
2021
Q3 		$270K Buy
2,247
+42
+2% +$4.89K ﹤0.01% 201
2021
Q2 		$264K Buy
+2,205
New +$242K ﹤0.01% 194

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WCM Investment Management's AZN Position: Q2 2026 in Review

WCM Investment Management opened a new position in AstraZeneca (AZN) in Q2 2026: 1,310,660 shares worth $249M. The stake represents 0.45% of the portfolio and ranks #44 among its holdings. This is a return to the name: WCM Investment Management previously reported a position in AZN as recently as Q4 2025.

WCM Investment Management first reported a position in AZN in Q2 2021 and has held it in 20 quarters since. The position peaked at $365M in Q2 2023. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • WCM Investment Management held 1,310,660 shares of AstraZeneca worth $249M as of Q2 2026.
  • AstraZeneca was a new WCM Investment Management position in Q2 2026.
  • AstraZeneca made up 0.45% of WCM Investment Management's portfolio in Q2 2026, its #44 holding.
  • WCM Investment Management first reported a position in AstraZeneca in Q2 2021 and has held it in 20 quarters since.
  • WCM Investment Management's AstraZeneca position peaked at $365M in Q2 2023.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.